Behaviour of opening and closing the jaw found in many animals
POPULARITY
Categories
Mike and Tom unwrap Bobo's PB&J Stuff'd Oat Bites to see if they're a hit or a miss. Join the MATES Club for even more snacking: https://realm.supportingcast.fm/matesclub Watch MATES on YouTube: https://www.youtube.com/@MikeAndTomEatSnacks Learn more about your ad choices. Visit megaphone.fm/adchoices
After a wild spooky season, Trevin and Amanda slow things down with a laid-back episode full of laughs, pets, and petty crimes. Trevin opens up about his chaotic October — from grief and illness to missing everything from his anniversary to Saw: The Parody Musical and Amanda's Halloween party. Amanda catches him up with stories from her “Frights & Bites” cook-off, sharing what he missed and tying it to the bizarre 2019 case of Jacob William Rogge, who robbed a High's convenience store in Baldwin, Maryland, while dressed as a unicorn. To turn his luck around, Trevin shares how he rescued two Shelties, Sammy and October, finding healing through puppy love. The headlines this week include:
Please subscribe to Patreon (through a web browser so Apple doesn't take 30%) for all bonus content plus one extra episode per week! https://www.patreon.com/duragandthedeertag Support the show and get 30% off your first Cornbread Hemp order. Use code DEERTAG at https://www.cornbreadhemp.com/DEERTAG Merch: https://topbananausa.com/durag-and-the-deertag/ @duragandthedeertag @dru_montana @naim__ali @goodboy_comedy
Following our previous Hammer Bites about "The Army Game", Cev's here to take a quick look at the life & career of Bernard Bresslaw, a man who casts a long shadow over Hammer in more ways than one!“The House Of Hammer Theme” and incidental music - written and produced by Cev MooreAll the links you think you'll need & more! https://linktr.ee/househammerpod
The principles of knowledge, intelligence, diligence, and obedience as found in D&C 130:18-21 go so nicely together in helping us become more like our Heavenly Father.
92Noon! Bears - VB - NFCN
92Noon! Bears - VB - NFCNSee omnystudio.com/listener for privacy information.
Local Houston celebrity Felice Sloan, aka the Swanky Maven, takes time from her busy autograph schedule to join Eric on today's show. The pair discuss some of the latest news including the upcoming opening of Doc's Houston and how things went at the first ever Bites & Beyond Festival this past weekend. In the Restaurants of the Week portion Murray's Pizza & Wine and 93' Til are featured. Follow Eric on Instagram/Threads @ericsandler. You can also reach Eric by emailing him at eric@culturemap.com. Check out some of his latest articles at Culturemap.com: Houston's New Retro-Styled Jazz Supper Club Sets Opening Date New Houston Food Festival Reveals Stacked Lineup of Restaurants and Music Running List of Veteran's Day 2025 Food and Drinks Deals in Houston Austin Burger Favorite Will Finally Open First Inside the Loop Location Luxurious Downtown Hotel Elevates with New Rooftop Restaurant
The manhunt is on for the monster who bit off an 88-year-old woman's finger for her ring, then ran off with both! His picture is circulating online. A drunk & 'deranged' son ditches his dying mom after he crashes their car. Plus, talk about driving justice home! Jennifer Gould reports. See omnystudio.com/listener for privacy information.
D&C 130 is jam packed with all kinds of doctrine designed to help us understand the true nature of God and help us love him even more.If you'd like to view the video that goes with the podcast, click here!
D&C 129 may seem like a pretty obscure section - and it kind of is, but you have to take into account that Joseph spoke with a lot of credibility on this subject. And there is definitely some application for us today.
On this episode, we recap week 9 of the NFL, the Bills beat the Chiefs again in the regular season, the Jets trade away some of their players, Jaylen Brown is tagging other players, the Dodgers win the World Series, JD's Bites, BRR's, and so much more!
Sal tries to find the issues on this Bills roster and why Joe Brady isn't fully to blame for the disconnect on offense. Why does this team struggle so much to play from behind? To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
Andrew Pollard is joined by the two-time TNA Knockouts Tag Team Champion, "The Wild Child" Jody Threat!Jody dives into the phenomenal success of TNA Wrestling's biggest year yet, including the record-breaking attendance at Bound For Glory and the incredible energy of nearly 8,000 fans. The Knockouts Division, Spitfire, Leon Slater's rise, Bumps & Bites, the WWE crossovers, Mercedes Moné, and more...ENJOY!Follow us on Twitter:@CulturedLeftPeg@WhatCultureWWE Hosted on Acast. See acast.com/privacy for more information.
Dr. Haojing Yan, professor of physics and astronomy at Mizzou's College of Arts and Science, talks about his research with NASA's James Webb Space Telescope on this edition of Brad's Bites.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The Constitution Study with Host Paul Engel – For anyone who's spent time in an arctic environment, you're probably aware of the dangers of frostbite. In politics, we seem to have found a new type of Arctic Frost Bite. Not the freezing of your fingers and toes, but a preverbal bite in the backside from the backlash from the Arctic Frost investigation...
Shining the spotlight on a special kind of daydream used as a source of comfort at times of high stress.Read the essay_____SubstackCorporate Speaking How to Build a Healthy Brain* Unprocessed: What Your Diet is Doing to Your Brain* Original music by Juan Iglesias *Affiliate links The information shared on this podcast is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you heard on this podcast. Reliance on any information provided here is solely at your own risk. Remember, your health is unique to you, so consult your healthcare provider for guidance tailored to your personal needs.Support this show http://supporter.acast.com/strongerminds. Hosted on Acast. See acast.com/privacy for more information.
I love Joseph Smith's excitement in D&C 128 about the work on both sides of the veil and it has carried over to our leaders today who share that same excitement for this most important cause!If you'd like to view the video that goes with podcast, click here!
Episode Overview: In this episode of Nomadic Diaries, co-hosts Megan Norton-Newbanks and Doreen Cumberford dive into the nuanced relationship between language and belonging. Drawing from their own global upbringings and experiences living in multiple countries, the hosts unpack how language—including dialects, family language mashups, and community-specific lingo—shapes our sense of home and connection.Key Topics Discussed:Mother Tongues & Dialects:Doreen Cumberford reflects on the comforting remnants of the Scots dialect from her childhood in Scotland, while Megan Norton-Newbanks shares how her family's unique blend of host languages creates a personal sense of home.Code-Switching, Acronyms & Systems:Megan Norton-Newbanks talks about adapting to the language systems of international schools and the Foreign Service, while Doreen Cumberford reminisces about mixing English and Arabic terms from her time in the Middle East.Language as Bridge & Barrier:The hosts discuss how English fluency both enables connection and, at times, hinders deeper integration with host cultures.Cultural Norms of Communication:Nuances in tone, pacing, and direct vs. indirect speech are highlighted as important for belonging—plus, the role of non-verbal language.Untranslatable Words:Doreen Cumberford and Megan Norton-Newbanks muse on favorite words from other languages (like the Japanese "Kamaribi") that capture feelings or phenomena English can't.The Emotional Impact of Language:Both hosts share stories of nostalgia, joy, and the complexity of reconnecting with community languages from their past.Listener Invitation: The episode closes with a warm call for listeners to share untranslatable words, stories, or reflections about how language shapes their sense of belonging.Languages Mentioned:Scots dialectEnglish (multiple versions!)ArabicJapaneseSpanishFrenchHungarianQuotable Moments:“It's almost like we're carrying the place and the people with us, isn't it?” “…language shapes belonging and not through just national or local tongues, but also through idioms and community specific ways of speaking.” –How to Connect: Do you have a story or an untranslatable word to share? The hosts would love to hear from you!Thank you for tuning in to Nomadic Diaries: Belonging-Bites3-Languages! If you enjoyed today's conversation, don't forget to subscribe and join the journey of exploring belonging across borders and languages.Support the showHome is Where Your Story Crosses Borders!We aim to inspire expat solutions, by helping you navigate global living with ease and grace.
The Constitution Study with Host Paul Engel – For anyone who's spent time in an arctic environment, you're probably aware of the dangers of frostbite. In politics, we seem to have found a new type of Arctic Frost Bite. Not the freezing of your fingers and toes, but a preverbal bite in the backside from the backlash from the Arctic Frost investigation...
Chloe McKean, Food Business Transformation Manager of The Food Foundation, tells us about a brand new campaign with Veg Power: Bang in Some Beans, which aims to double the consumption of beans in the UK by 2028.Click here to sign up for The Food Foundation newsletter and here for more information on the Bang in Some Beans campaign. Hosted on Acast. See acast.com/privacy for more information.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
Are you craving a homemade soup that's a full meal in a bowl?In this bite-sized episode, we share delicious moments about the best things we ate this week to inspire each other – and you!By the end of this episode, you'll want to cook up a pot of Ina Garten's Italian Wedding Soup — a flavorful classic filled with tender chicken meatballs, fresh spinach, and pasta in rich chicken broth.And you'll want to make our favorite sweet, simple, no-bake peanut butter granola bars. They're inspired by a nostalgic snack, and are perfect for packing up for lunch or travel. Tune in for a quick dose of home cooking inspiration that will warm your kitchen and your week!***Links:Ina Garten's Italian Wedding Soup The original Samak StickiesHow to make Kari's homemade version of “No-bake PB & Honey Stickies”NOTE: Process mixture finely so that it will pack well, and use very creamy peanut butter; the natural varieties do not work as well in this recipe. If your bars are crumbly and falling apart, dabbing a bit more peanut butter will help bind it together. Process and pulse 1 cup roasted salted peanuts in a food processor until roughly choppedAdd 2 cups Grape Nuts Cereal (or similar) and pulse until finely chopped, then transfer to a large mixing bowlGently heat 1 cup creamy peanut butter + ⅓ cup honey + ½ tsp vanilla paste; stir until smooth and creamyPour peanut butter mixture over the cereal mixture, then combine with (clean) hands until fully incorporatedUse a 2” scoop to pack and portion into individual balls, then use your hands to flatten into a puck shapeCan be eaten as is, or kept on the counter in an airtight container. You can also freeze them!This is a great recipe for teenagers and kids who are interested in helping in the kitchen! ***Got a cooking question? Leave us a message on our hotline at: 323-452-9084For more recipes and cooking inspiration, sign up for our Substack here. You can also now find us on YouTube. We love hearing from you — follow us on Instagram @foodfriendspod, or drop us a line at foodfriendspod@gmail.com!Looking for an in-person Food Friends experience? Book a farmers' market tour with Sonya in Portland, OR!
This week on The Horse Race, Jenn and Steve are joined by Rich Parr, VP of The MassINC Polling Group for an in depth discussion about the elections on Tuesday. Dems had a big night, winning seats across the country. What does this spell for Trump 2.0? What trends do the voting stats reveal? https://boltsmag.org/ https://www.umass.edu/political-science/about/reports/2025-12#toc-toplines-and-crosstabs https://www.umass.edu/news/article/kennealy-holds-early-lead-2026-bay-state-gop-gubernatorial-primary-nod-according-new https://commonwealthbeacon.org/newsletter/competitive-mayoral-races-abound-just-not-in-boston/
According to Joseph Smith, what subject is “the most glorious of all subjects belonging to the everlasting gospel”? You'll see in D&C 128…
Dr. Monty Pal and Dr. Pauline Funchain discuss the latest efforts to diagnose, prevent, and treat the series of immune-related adverse events that have emerged in the era of immunotherapy. TRANSCRIPT Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I am Monty Pal, a medical oncologist, professor and vice chair of medical oncology at the City of Hope Comprehensive Cancer Center in Los Angeles, California. Now, it is probably no surprise to this audience that immunotherapy has transformed the treatment landscape for multiple cancer types. It remains a pillar of modern oncology. Having said that, I think we have all been baffled by certain toxicities that we run into in the clinic. Today, I am delighted to be joined by Dr Pauline Funchain to discuss some of the checkpoint inhibitor toxicities that people struggle with most. And we will also touch on some side effects of immunotherapy beyond checkpoint inhibitors: CAR-T cells, bispecifics, so on and so forth. Dr Funchain is a dear friend, and she is an associate professor and associate director of cancer research training and education at the Stanford Cancer Institute. She is co-director of the Immunotherapy Toxicity Program and the Skin Cancer Genomics Program at Stanford, where she also serves as associate program director of hematology and oncology fellowship. Dr. Funchain is also the co-founder of ASPIRE, and we are going to talk about that a little bit today, the Alliance for the Support and Prevention of Immune-Related Events. FYI for listeners, if you are interested in our disclosures, they are available at the transcript of this episode. Pauline, thanks so much for joining us today. Dr. Pauline Funchain: Monty, thank you for this invitation. It is always great to talk. Dr. Monty Pal: So, for the audience, Pauline and I know each other from my days as a fellow at City of Hope. She was a resident at Harbor UCLA and a stellar resident at that. It has just been amazing to sort of see your career grow and blossom and to witness all the cool things that you are doing. ASPIRE, in particular, sort of caught my eye. So again, for listeners, this is the Alliance for the Support and Prevention of Immune-Related Events. Can you tell us a little bit briefly about the genesis of that, how that came about? Dr. Pauline Funchain: So, there was a bunch of us who were really struggling, I mean, all of us have struggled with these immune-related adverse events, these irAEs. You know, they are new disease states, and even though they look like autoimmune diseases, they tend to need a whole lot more steroid than autoimmune diseases do and they do not totally present in the same way. And in fact, you know, Triple-M, or Triple-M overlap syndrome, is a completely new irAE, a new immune state that we have never had before the advent of checkpoint inhibitor. And so a Triple-M, for those of you who are not as familiar, that is the constellation of myocarditis, myositis, and myasthenia gravis, something that never occurs as a natural autoimmune disease. So we were starting to realize that there were some major differences with these irAEs and autoimmune diseases. We could not treat them the right way. We really needed to learn more about them. And a bunch of us who had interest in this said, "Look, we really need to be all in one space to talk about what we are doing," because all of our treatments were our own little homegrown brews, and we needed to really get together and understand how to treat these things, how to diagnose them, and then learn more about them. So, Dr. Alexa Meara from Ohio State, Dr. Kerry Reynolds from Mass Gen, we put together this research consortium, brought together all of our irAE friends, got our best subspecialists together in a research consortium, which is now only about a year and a half old. And we made this research consortium, the Alliance for Support of Prevention of Immune-Related Events, and we reached out to ASCO, and ASCO was so kind to grant us a [Alliance for Support and Prevention of Immune-Related adverse Events (ASPIRE)] Community of Practice. So we met for the first time as a Community of Practice at the ASCO Annual Meeting just this past June and really got an ASCO community together to really think about how to again, diagnose, prevent, treat irAEs. Dr Monty Pal: This is interesting to me. The ASCO Community of Practice phenomenon is something that I was not super familiar with. Can you explain to our listenership what is the ASCO Community of Practice model? If you have particular interests, how do you sort of get one started? Dr Pauline Funchain: Yeah, so ASCO has an entire page on their Community of Practice. There are multiple Community of Practice groups or COPs. There are ones for Supportive Oncology and Survivorship. There is Women in Oncology. There is a group for International Medical Graduates. And there is about, I think 10 or 12 now that have a physical presence at ASCO but also a virtual presence on the ASCO Community of Practice site. So, if you were interested in any one of these, and you can see them on the ASCO Communities of Practice sites, you would ask to become a member. Once granted membership, then there is a whole webpage of postings and conversations that people can have. You can get email digests of conversations that happen on the website, and then you can anchor it with in-person participation at the Annual Meeting. Dr Monty Pal: That is awesome, and I can think of so many different foci within oncology that really sort of deserve a Community of Practice. This definitely being one of them. You know, it strikes me as being so interesting. I mean, the checkpoint inhibitors have been around for a while now. I think when you and I were in training, gosh, back then, these were just a little bit of a pipe dream, right? But having said that, I would probably say that more than half of my kidney cancer practice is either on checkpoint inhibitors, and the vast majority have been on one at some point in their past, right? With that in mind, you know, we have all treated a lot of patients with these drugs. Why is it that we still struggle to manage the toxicities? And just to take that one step further, what are some of the toxicities that, perhaps through ASPIRE or through your experience, people struggle with the most? Dr Pauline Funchain: So, I think we are still struggling with these because again, they are new disease states, right? This is what we all experienced with COVID, a brand-new virus and a brand-new syndrome. We now have 20-plus of these as irAEs. And what we have realized about them is the immune activation that happens with these is so much more than what we have seen with autoimmune diseases. So for instance, if you have a Crohn's or ulcerative colitis, you will top out at 40 to 60 milligrams of prednisone if a Crohn's flare or ulcerative colitis flare happens. But for our severe IR colitises, you know, it is at least 1 mg per kg, often goes up to 2 mg per kg. We, in some cases, have done 1 gram pulses if we are worried that somebody is going to perforate. So that was sort of like the first 5 years of treating irAE, and then now in the sort of second 5 years of treating irAE, we have realized that that is a lot of immunosuppression, and we might be able to get away with less with the newer biologics that are on board. So, we are struggling to try to get the data for some of these irAEs that we knew, we have known for a while, but to try to get newer treatments that may immunosuppress less so that you may still be able to retain that tumor response. And in fact, some of the preclinical studies suggest that some of these biologics may actually synergize with the immunotherapy and actually make the immunotherapy more effective from a tumor perspective and calm down the irAE as sort of the bystander effect. So we are still trying to optimize those. Getting up trials in the space has been very difficult. That is one of the reasons for the genesis of ASPIRE because we realized we needed to band together to have a bigger voice in that realm. Then there are other things that are brand new. So we talked about Triple-M. So Triple-M, again, with Triple-M or any myocarditis or myasthenia, I mean, there is about a 50% chance of death from irAE based on the literature. I think we are getting better at recognizing this, and so at Stanford we have some data to say that if you serially follow troponin, that maybe your outcomes are better. You can potentially lower the percentage of cases that are fatal because you can catch them early. I mean, this is all preliminary data, but again, these are all things that are evolving, and we do not all have the right answer. I mean, even the serial troponin thing, I think, is pretty controversial. And in fact, at one of our quarterly Zoom meetings that we are doing in ASPIRE in December is going to sort of flush out that controversy about serial troponin measuring and what is the best thing to use? Would you use something like abatacept or would you use ruxolitinib? Which one is better? I think there is a lot of controversy still about these things. Dr Monty Pal: You have really piqued my curiosity here because you think about the cons of treating irAEs, right? And I worry exactly about what you had mentioned, right, which is, "Gosh, what is going on with this tumor in terms of immunosuppression?" But you think about some of the newer agents, you mentioned ruxolitinib, I have heard of dasatinib, for instance, in this setting. Frankly speaking, a lot of these, as you point out, are really thought of as being also anticancer drugs. So you have really got me thinking about the potential synergy between perhaps suppressing an irAE and augmenting antitumor activity, which I think is very interesting. Am I on the right track with that? Dr Pauline Funchain: I think so, but you will find that a lot of people will not even go there because they are worried about how much immunosuppression you are going to cause. I am at heart a geneticist, but I think an immunologist will happily tell you that the immune system is very complex. There are multiple pathways, and these drugs do not all target the same immune pathways. So if we understand a little bit more about the pathways we are targeting and pick apart the pathways that are really, really tumor relevant and the other pathways that are not tumor relevant, you may be able to piece together a better marriage of tumor response and irAE control. Dr Monty Pal: Kind of on this topic, and again, leaning on your background in genetics, where are we in terms of predicting these irAEs? I mean, you would think the holy grail would be picking out a snip or something of this for it, right, that could potentially identify that patient who is going to get Triple-M or, you know, at the very least a significant high-grade irAE event. Are we anywhere closer to that in 2025? Dr Pauline Funchain: There have been data published. There have been some big GWAS studies. All of the effect sizes are pretty small. So there are some prediction algorithms, but none of them are clinically useful. And I think when you look at the odds ratios, they will increase risk by maybe 20%. I think one of the things that we found in a very small series and supported anecdotally is something as easy as family history of autoimmune disease is probably more predictive at this point than any of those types of markers. I think we will get there, but we are not anywhere near where we would like to be. Things like TMB also, actually, there is some good data about higher TMB, higher risk of irAE too. Dr Monty Pal: Interesting. I see all this data coming through, IL-8 polymorphisms, etc. And I just wondered if any of that was ready for prime time. But I mean, this is a good message for the practicing clinician. Sounds like we are not quite there yet. And I could probably keep you on for another entire podcast to talk about this topic, but let us see if we can at least skim the surface. I never thought I would see the day when BiTEs and CAR-Ts were entering into my kidney cancer practice, but in fact, it is really become central to a lot of our clinical trials in RCC these days. I would be lying if I did not say that I was not struggling with the toxicities and so forth associated with these drugs. Can you give us a quick primer, maybe just good resources that people can go to for managing toxicity with BiTEs and with CAR and with some of these novel therapeutic modalities that we are using in the oncology clinics? Dr Pauline Funchain: I know there is a recently published toxicity manual for BiTEs in hematologic malignancies, I think it was in Blood. CAR-T is covered in many irAE guidelines. So ASCO guidelines actually has a CAR-T [cell therapy guideline], and I would be remiss not to point out that actually ASCO has a, I am a little biased, but a wonderful guideline on irAE that is actually being updated as we speak. We are hoping for publication next year. I find the format of that, there are many guidelines out there, actually. There is ASCO, SITC, ESMO has a guideline for irAE, but I find the formatting of the ASCO guideline to be much easier to flip through during clinic, just because of the visual format of the tables. But that is going to be updated next year. And with CAR-T, there is now multiple publications also in terms of guidelines. But what I will say about bispecifics and CAR-T, so they have very similar toxicities in terms of the cytokine release and also with the ICANS, so the neurotoxicity. But what we have been finding that is really interesting with BiTEs and CAR-T, and actually even with TIL, cytokine release is very similar to some of the IL-2 toxicities but not identical that we see with TIL treatment. But now we are starting to see overlap. So patients who have been treated with immunotherapy and then go on to get a bispecific or then go on to get TIL, so I have seen some colitises that have occurred after the fact. Some of the newer CAR-Ts without checkpoint have been causing some really interesting, probably not in a good way, but interesting biologically, colitises that are really refractory. So we are starting to see some overlap, and again, I think this field is just evolving constantly. Dr Monty Pal: Yeah, no, I almost think I need to go back to that fellowship that you and I did together 20 years ago and, you know, and see if I could repeat some coursework on CAR-T management. You know, Pauline, I could probably keep you on the horn for hours, but this has just been terrific. Thank you so much for sharing all of your insights with us today on the ASCO Daily News Podcast. Dr Pauline Funchain: Thank you for the invitation. It was wonderful to talk about this, and it was wonderful to catch up a little bit, Monty. Dr Monty Pal: Same here, same here. And thanks to our listeners too. If you value the insights you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers: Dr. Monty Pal @montypal Dr. Pauline Funchain @FunchainMD Follow ASCO on social media: @ASCO on Twitter ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Monty Pal: Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis Dr. Pauline Funchain: Consulting or Advisory Role: Merck, Replimune, Sanofi/Regeneron, Immunocore, Tempus Research Funding (Inst.): Pfizer, Bristol-Myers Squibb, IDEAYA Biosciences, Linnaeus Therapeutics Travel, Accommodations, Expenses: Merck
Big Four at Four with Steve and Adam C, Behind the Counter with Ray Cleaver, Steve Kim talking Fighting and CFB
It's well known how many BBC properties were transferred to the silver screen by Hammer through its early years, but Smokey's here with the beginnings of what became a very fruitful relationship with ITV...“The House Of Hammer Theme” and incidental music - written and produced by Cev MooreAll the links you think you'll need & more! https://linktr.ee/househammerpod
While Joseph is in hiding for a few months, he teaches us some amazing things from D&C 127…the first of which is how to stay positive in the midst of difficult trials.
Sal and Matt share a quick discussion on the last two Bills draft classes and if the play of the picks this year is changing their mind at all. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
The latest in AE Victory Racing's roster of empowering women in motorsport, Alana Carter is taking every opportunity she can. Born in rural Canada to a racing family, Alana's career started at a young age on the local short track scene, where she eventually conned her way into a road racing career by lying about […]
92Noon! Vikes - VB - PropsSee omnystudio.com/listener for privacy information.
92Noon! Vikes - VB - Props
As we are striving to serve faithfully in our church service, we often need to be reminded that our greatest opportunities for service are right in front of us in our own homes.If you'd like to view the video that goes with podcast, click here!
More of the funniest reviews on the internet! We read reviews for a 600 year old castle, in the UK, where people seem to be very angry at the lack of modern amenities, among other things. A side of the road Florida bar & grill, specializing in "gator bites" & rudeness to non locals. A motel that seems to take great pride in not having what you need & much more!! Join comedians James Pietragallo & Jimmie Whisman as they explore the most opinionated part of the internet: The Reviews Section! Subscribe, and we will see you every Monday with Your Stupid Opinions!! Dont forget to rate & review!! Go to shutupandgivememurder.com for merch & more Check out James & Jimmie's other podcasts, Small Town Murder & Crime In Sports on Apple Podcasts, Spotify, or wherever you listen to podcasts!!
On the surface, D&C 125 doesn't appear to be all that impressive, but there is a great little principle found in this short section that can apply to us all in a big way!If you'd like to view the video that goes with podcast, click here!
Massive Snake Surge Hits Queensland: Catchers Inundated by Eastern Browns and Red Bellies. Jeremy Zakis discusses how predictions of a snake boom came true in Darling Downs, Queensland, where sightings and bites have soared, potentially tripling last year's numbers. Snake catchers are overwhelmed by the volume of calls. The warm, wet spring accelerated breeding cycles, putting many snakes—including pythons, Eastern Brown snakes, and Red Belly Black snakes—on the move. Eastern Brown snakes are highly aggressive and dangerously fast, with venom that can be fatal within an hour, while Red Belly Black snakes tend to paralyze their prey. Retry
Ghost Bites is a weekly podcast from Mike and J.T. of Brew Crime, for quick, 5–10 minute dives into the haunted, spooky, and paranormal. Get your weekly dose of all things creepy, served with a side of laughs. It's the perfect podcast for anyone looking for a fun and frightening experience that won't take up their whole day.This week on Ghost Bites, Mike and J.T. crack open the creepy tale of the Dybbuk Box. Allegedly a wine cabinet possessed by a restless, dislocated spirit, this little antique has a reputation for bringing misfortune, nightmares, and even physical harm to anyone who dares to own it. Join us as we explore this potentially furniture-based evil entity and ponder if buying haunted antiques on eBay is ever a good idea. Spoiler: it's not.Sources used for this episode:The Dybbuk Box by Jason Haxton"A Nightmare on Elm Drive: The True Story of the Dybbuk Box" (documentary)"The Haunted Dybbuk Box: A True Story of Possession?" (All That's Interesting article)The Possession (2012 film, for entertainment purposes only, definitely not a documentary)Intro Music by - Jayme McDonald (Chatterless) Spotify, Linktree Become a supporter of this podcast: https://www.spreaker.com/podcast/reverie-true-crime--4442888/support.
From a student in India training to be an MRI technician to a food creator in Singapore making viral ASMR feasts — Nalla Iruku's journey is as unique as his dishes.In this episode, Bharath sits down with the Singapore-based creator to talk about how he turned kitchen chaos into creative success. Once known for burning pots, Nalla Iruku now crafts the perfect food sounds that make you hungry through your screen. He shares stories of his chilli halwa disaster, the best dishes he's ever made, and how working in Singapore shaped his consistency and confidence as a content creator.A fun, flavour-packed chat about chasing passion, learning through fails, and staying true to your roots; this one will leave you saying “Nalla Iruku!”==========Don't forget to like, comment and subscribe to our YouTube and other social channels to never miss an update. Thank you for your support and we look forward to sharing more exciting content with you soon!
This week's Buffalo Beer Buzz is here with stories on what breweries, cideries and meaderies are pouring at Bottles & Bites, the 21st annual Holiday Valley Beer & Wine Festival, cask beer galore for the rest of the year at Mr. Goodbar, including VIP Cask Night, weekly tappings and the return of Winter Cask Fest, a new lager from Wayland Brewing and Queen City Vintage, new fruited sours from Thin Man Brewery and Southern Tier Brewing Co. - Buffalo, and new cask and side pull beers and Hawaiian BBQ at Buffalo Brewing. Hosted on Acast. See acast.com/privacy for more information.
-Curtis Sliwa clashes with Rob Finnerty, leading Rob to crown the New York mayoral race a “crap sandwich showdown” featuring Cuomo and “Zoron Mondami, the Marxist Muslim radical.” -Gordon Chang joins the Newsmax hotline to praise Trump's Asia trip, where Trump supposedly outmaneuvers China, charms Japan, and makes the world dance to “YMCA.” Today's podcast is sponsored by : BEAM DREAM POWDER : Improve your health by improving your sleep! Get 40% off by using code NEWSMAX at http://shopbeam.com/NewsmaxGET FRESH OLIVE OIL : Try real farm fresh olive oils for FREE plus $1 dollar shipping at http://GetFreshRobCarson.comBIRCH GOLD - Protect and grow your retirement savings with gold. Text ROB to 98 98 98 for your FREE information kit! To call in and speak with Rob Carson live on the show, dial 1-800-922-6680 between the hours of 12 Noon and 3:00 pm Eastern Time Monday through Friday…E-mail Rob Carson at : RobCarsonShow@gmail.com Musical parodies provided by Jim Gossett (www.patreon.com/JimGossettComedy) Listen to Newsmax LIVE and see our entire podcast lineup at http://Newsmax.com/Listen Make the switch to NEWSMAX today! Get your 15 day free trial of NEWSMAX+ at http://NewsmaxPlus.com Looking for NEWSMAX caps, tees, mugs & more? Check out the Newsmax merchandise shop at : http://nws.mx/shop Follow NEWSMAX on Social Media: -Facebook: http://nws.mx/FB -X/Twitter: http://nws.mx/twitter -Instagram: http://nws.mx/IG -YouTube: https://youtube.com/NewsmaxTV -Rumble: https://rumble.com/c/NewsmaxTV -TRUTH Social: https://truthsocial.com/@NEWSMAX -GETTR: https://gettr.com/user/newsmax -Threads: http://threads.net/@NEWSMAX -Telegram: http://t.me/newsmax -BlueSky: https://bsky.app/profile/newsmax.com -Parler: http://app.parler.com/newsmax Learn more about your ad choices. Visit megaphone.fm/adchoices
A new super earth in the habitable zone. Did Jupiter save the early Earth? Astronomers see three-eye Atlas as it passes behind the sun. The X-59 quiet supersonic plane gets tested. And in Space Bites Plus, do re-entering satellites put the wrong kinds of metals in the atmosphere? All this and more in this week's Space Bites.Watch the video here (with no ads) or on YouTube: https://youtu.be/ZdmN7a7NDY0
D&C 124:49 is for anyone whose missions have been cut short for whatever myriad of reasons that are out there. The Lord loves you and is very mindful of your situation.If you'd like to view the video that goes with podcast, click here!
On this Episode, we discuss week 8 of the NFL, the Giants take a double loss, how dangerous are the Chiefs?, the best games for week 9 of the NFL, the NBA and it's Gambling problem, World Series, JD's Bites, BRR's, and so much more!
Jordan and Max return to answer audience questions, and it's the one big restaurant gimmick, seed oil freaks, sauna and ice, and spas, pricey tasting menus, the problems with Hilstone, managing generally, Thanksgiving protiens, Diddy Riese ice cream sandwich construction, Max's height and bubble intake, and too much tippy.
Timberwolves coach Chris Finch kicks off the show, then some Vikes Bites and NFL fodder throughout the first hour!
Timberwolves coach Chris Finch kicks off the show, then some Vikes Bites and NFL fodder throughout the first hour!See omnystudio.com/listener for privacy information.
Looking for the perfect make-ahead menu for hosting on a chilly fall evening? In this bite-sized episode, we share the best things we ate this week to inspire each other and you!By the end of this episode, you'll be craving Julia Child's classic boeuf bourguignon; it's famous for a reason, with tender beef and a rich, velvety sauce. You'll also pick up our tips for making the best apple-cranberry crisp – a dessert that's impressive enough for your next dinner party, or even for brunch! Tune in for a quick dose of home cooking inspiration!***Links:Julia Child's Boeuf Bourguignon Apple Crisp recipe from The Chunky Chef. To make Kari's breakfast/brunch version, sub maple syrup for the sugar in the apples, and bake them with cranberries in the oven until tender and jammy. Mix up crumble topping and bake SEPARATELY from the fruit for added crunch (use gf oats if you like!). Add crumble topping to roasted fruit before serving. Offer whole milk Greek yogurt as an optional topping!***Got a cooking question? Leave us a message on our hotline at: 323-452-9084For more recipes and cooking inspiration, sign up for our Substack here. You can also now find us on YouTube. We love hearing from you — follow us on Instagram @foodfriendspod, or drop us a line at foodfriendspod@gmail.com!Looking for an in-person Food Friends experience? Book a farmers' market tour with Sonya in Portland, OR!
One of the coolest scripture study skills is to place your name in the scriptures in place of another individual and see how it sounds. Well, there are 60 people mentioned by name in D&C 124 as Nauvoo is being organized. Did all of them stay faithful to their promised blessings?If you'd like to view the video that goes with podcast, click here!
Ex Colombo Crime Family Member Michael Franzese speaks on how professional athletes find themselves dealing with an addiction to gambling. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices